Traws Pharma, Inc. (TRAW)
NASDAQ: TRAW · Real-Time Price · USD
1.370
-0.110 (-7.43%)
At close: Jun 5, 2026, 4:00 PM EDT
1.357
-0.013 (-0.93%)
Pre-market: Jun 8, 2026, 7:53 AM EDT
Traws Pharma Market Cap
Traws Pharma has a market cap or net worth of $20.76 million as of June 8, 2026. Its market cap has increased by 210.86% in one year.
Market Cap
20.76M
Enterprise Value
17.62M
1-Year Change
210.86%
Ranking
Category
Stock Price
$1.37
Market Cap Chart
Since July 25, 2013, Traws Pharma's market cap has decreased from $409.28M to $20.76M, a decrease of -94.93%. That is a compound annual growth rate of -20.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 20.76M | 129.87% |
| Dec 31, 2025 | 9.03M | -72.02% |
| Dec 31, 2024 | 32.27M | 106.05% |
| Dec 29, 2023 | 15.66M | 15.90% |
| Dec 30, 2022 | 13.51M | -74.64% |
| Dec 31, 2021 | 53.27M | -38.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| VYNE Therapeutics | 21.86M |
| Vistagen Therapeutics | 21.55M |
| Longeveron | 21.38M |
| Cellectar Biosciences | 20.70M |
| CEL-SCI | 19.86M |
| Sensei Biotherapeutics | 19.66M |
| Pasithea Therapeutics | 19.55M |
| Werewolf Therapeutics | 19.06M |